<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">J Gastrointest Surg</journal-id>
      <journal-title>Journal of Gastrointestinal Surgery</journal-title>
      <issn pub-type="ppub">1091-255X</issn>
      <issn pub-type="epub">1873-4626</issn>
      <publisher>
        <publisher-name>Springer-Verlag</publisher-name>
        <publisher-loc>New York</publisher-loc>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">17436130</article-id>
      <article-id pub-id-type="pmc">1852383</article-id>
      <article-id pub-id-type="publisher-id">116</article-id>
      <article-id pub-id-type="doi">10.1007/s11605-007-0116-0</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Article</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Liver Transplantation Across Rh Blood Group Barriers Increases the Risk of Biliary Complications</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author" corresp="yes">
          <name name-style="western">
            <surname>Busquets</surname>
            <given-names>Juli</given-names>
          </name>
          <address>
            <phone>+34-93-2483244</phone>
            <fax>+34-93-2483433</fax>
            <email>jbusquets@csub.scs.es</email>
          </address>
          <xref ref-type="aff" rid="Aff1">1</xref>
          <xref ref-type="aff" rid="Aff5">5</xref>
        </contrib>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Castellote</surname>
            <given-names>Jose</given-names>
          </name>
          <xref ref-type="aff" rid="Aff2">2</xref>
        </contrib>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Torras</surname>
            <given-names>Jaume</given-names>
          </name>
          <xref ref-type="aff" rid="Aff1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Fabregat</surname>
            <given-names>Juan</given-names>
          </name>
          <xref ref-type="aff" rid="Aff1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Ramos</surname>
            <given-names>Emilio</given-names>
          </name>
          <xref ref-type="aff" rid="Aff1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Llado</surname>
            <given-names>Laura</given-names>
          </name>
          <xref ref-type="aff" rid="Aff1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Rafecas</surname>
            <given-names>Antonio</given-names>
          </name>
          <xref ref-type="aff" rid="Aff1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>de la Banda</surname>
            <given-names>Esmeralda</given-names>
          </name>
          <xref ref-type="aff" rid="Aff3">3</xref>
        </contrib>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Figueras</surname>
            <given-names>Juan</given-names>
          </name>
          <xref ref-type="aff" rid="Aff4">4</xref>
        </contrib>
        <aff id="Aff1"><label>1</label>Department of Surgery, Hospital Universitari de Bellvitge, Barcelona, Spain </aff>
        <aff id="Aff2"><label>2</label>Department of Gastroenterology, Hospital Universitari de Bellvitge, Barcelona, Spain </aff>
        <aff id="Aff3"><label>3</label>Department of Haematology, Hospital Universitari de Bellvitge, Barcelona, Spain </aff>
        <aff id="Aff4"><label>4</label>Department of Surgery, Hospital Josep Trueta, Girona, Spain </aff>
        <aff id="Aff5"><label>5</label>Hospital Universitari de Bellvitge, c/ Feixa Llarga s.n., 08907 Barcelona, Spain </aff>
      </contrib-group>
      <pub-date pub-type="epub">
        <day>26</day>
        <month>1</month>
        <year>2007</year>
      </pub-date>
      <pub-date pub-type="ppub">
        <month>4</month>
        <year>2007</year>
      </pub-date>
      <volume>11</volume>
      <issue>4</issue>
      <fpage>458</fpage>
      <lpage>463</lpage>
      <permissions>
        <copyright-statement>&#xA9; The Society for Surgery of the Alimentary Tract 2007</copyright-statement>
      </permissions>
      <abstract>
        <sec>
          <title>Background</title>
          <p>Cold ischemia time and the presence of postoperative hepatic arterial thrombosis have been associated with biliary complications (BC) after liver transplantation. An ABO-incompatible blood group has also been suggested as a factor for predisposal towards BC. However, the influence of Rh nonidentity has not been studied previously.</p>
        </sec>
        <sec>
          <title>Materials</title>
          <p>Three hundred fifty six liver transplants were performed from 1995 to 2000 at our hospital. BC incidence and risk factors were studied in 345 patients.</p>
        </sec>
        <sec>
          <title>Results</title>
          <p>Seventy patients (20%) presented BC after liver transplantation. Bile leakage (24/45%) and stenotic anastomosis (21/30%) were the most frequent complications. Presence of BC in Rh-nonidentical graft&#x2013;host cases (23/76, 30%) was higher than in Rh-identical grafts (47/269, 17%) (<italic>P</italic>&#x2009;=&#x2009;0.01). BC was also more frequent in grafts with arterial thrombosis (9/25, 36% vs 60/319, 19%; <italic>P</italic>&#x2009;=&#x2009;0.03) and grafts with cold ischemia time longer than 430&#xA0;min (26/174, 15% vs 44/171, 26%; <italic>P</italic>&#x2009;=&#x2009;0.01). Multivariate logistic regression confirmed that Rh graft&#x2013;host nonidentical blood groups [RR&#x2009;=&#x2009;2(1.1&#x2013;3.6); <italic>P</italic>&#x2009;=&#x2009;0.02], arterial thrombosis [RR&#x2009;=&#x2009;2.6(1.1&#x2013;6.4); <italic>P</italic>&#x2009;=&#x2009;0.02] and cold ischemia time longer than 430&#xA0;min [RR&#x2009;=&#x2009;1.8(1&#x2013;3.2); <italic>P</italic>&#x2009;=&#x2009;0.02] were risk factors for presenting BC.</p>
        </sec>
        <sec>
          <title>Conclusion</title>
          <p>Liver transplantation using Rh graft&#x2013;host nonidentical blood groups leads to a greater incidence of BC.</p>
        </sec>
      </abstract>
      <kwd-group>
        <title>Keywords</title>
        <kwd>Liver transplantation</kwd>
        <kwd>Biliary complications</kwd>
        <kwd>Rh nonidentity</kwd>
      </kwd-group>
      <custom-meta-wrap>
        <custom-meta>
          <meta-name>issue-copyright-statement</meta-name>
          <meta-value>&#xA9; The Society for Surgery of the Alimentary Tract 2007</meta-value>
        </custom-meta>
      </custom-meta-wrap>
    </article-meta>
  </front>
  <body>
    <sec id="Sec1" sec-type="introduction">
      <title>Introduction</title>
      <p>Biliary complications (BC) after liver transplantation (LT) are still a significant cause of morbidity and mortality.<xref ref-type="bibr" rid="CR1">1</xref>,<xref ref-type="bibr" rid="CR2">2</xref> Hepatic arterial thrombosis, long ischemia time, inadequate exposure of the biliary epithelium to the preservation solution, and chronic rejection have been associated with BC.<xref ref-type="bibr" rid="CR3">3</xref>&#x2013;<xref ref-type="bibr" rid="CR5">5</xref> However, complications may also occur in the absence of these pathogenic factors. The expression of donor ABH antigen in the vascular and biliary epithelium of hepatic allografts has been linked to higher risk of biliary and arterial complications, especially in ABO-incompatible grafts.<xref ref-type="bibr" rid="CR6">6</xref> However, the influence of Rh nonidentity in LT has not been analyzed until now.</p>
      <p>The aim of this study is to analyze the incidence of BC after LT, to define their etiological risk factors, and to study the influence of Rh nonidentity on presentation of BC after LT.</p>
    </sec>
    <sec id="Sec2" sec-type="materials">
      <title>Materials</title>
      <p>Three hundred and fifty-six (<italic>n</italic>&#x2009;=&#x2009;356) liver transplants were performed at our hospital between January 1995 and November 2000. Eleven were excluded from the study because important data were missing (<italic>n</italic>&#x2009;=&#x2009;345). The study was closed on May 2001 with a 6-month-minimum graft follow-up. The procurement procedure was based on the rapid flush technique.<xref ref-type="bibr" rid="CR7">7</xref> After reperfusion of the allograft, cholecystectomy was performed, the donor bile duct being divided just above the cystic duct junction in most cases. Biliary anastomosis was performed with interrupted stitches of 6-0 Polydioxanone suture Ethicon&#xAE; (Johnson &amp; Johnson, Brussels, Belgium). The biliary reconstruction technique was end-to-end anastomosis in the majority of LTs (315 patients, 91%). T-tubes were used in four patients due to diameter discrepancy between the biliary ducts of the donor and the recipient. If the primary disease affected the biliary tract, or if technical factors made end-to-end anastomosis difficult, Roux-en-Y-hepaticojejunostomy was performed (25 out of 345, 7%). The outcome was assessed in terms of biliary and arterial complications and patient status (alive, retransplanted, or dead). BCs were studied routinely with abdominal ultrasonography at day&#xA0;1 post LT, weekly before discharge from hospital and monthly thereafter or when there was clinical or biochemical suspicion of BC, and this was confirmed with magnetic resonance cholangiography, percutaneous transhepatic cholangiography, or endoscopic retrograde cholangio-pancreatography when necessary. The immunosuppressive regimen was based on quadruple sequential therapy with antilymphocyte globulin, Sandimmune Neoral&#xAE; (Novartis, Basel, Switzerland), steroids, and azathioprine in most patients, as reported elsewhere.<xref ref-type="bibr" rid="CR8">8</xref> Cellular rejection was diagnosed according to histological criteria.<xref ref-type="bibr" rid="CR9">9</xref></p>
      <p><bold>Statistical analysis</bold> Chi-squared analysis was used to compare dichotomous variables and the presence of BC. Variables that were statistically significant in the univariate analysis were introduced in a multivariate logistic regression analysis. Other known risk factors for developing BC were introduced into the model as covariates: donor age, acute rejection, and chronic rejection. Variables with <italic>P</italic>&#x2009;&gt;&#x2009;0.05 were excluded from the final equation. Kaplan&#x2013;Meier estimates of the rate of BC for both groups and the results were compared with a log-rank test.</p>
    </sec>
    <sec id="Sec3" sec-type="results">
      <title>Results</title>
      <p><bold>Perioperative data and surgical details</bold> The preservation solutions used were the University of Wisconsin solution in 332 (97%), Celsior solution in 5 (1%), and histidine-tryptophan-ketoglutarate solution in 8 (2%). Twenty grafts (6%) were shipped by another team. The study of donor risk factors demonstrated that there was no hemodynamic instability (systolic pressure lower than 60&#xA0;mmHg for more than 1&#xA0;h) in 265 cases (77%), and that the main cause of death was traumatic head injury (129/36%). Donor Rh blood group was positive in 301 (87%) and negative in 44 cases (13%). Recipient Rh blood group was positive in 284 (82%) patients, and negative in 61 (18%). Rh blood groups of donor and recipient were positive to positive in 255 cases (74%), positive to negative in 46 (13%), negative to positive in 30 (9%), and negative to negative in 14 (4%). Donors and recipients had identical Rh in 269 cases (78%) and nonidentical in 76 (22%). The donor ABO blood group was A in 157 (46%), B in 29 (8%), AB in 19 (5%), and O in 140 (41%), while recipients were A in 161 cases (46%), B in 34 (10%), AB in 20 (6%) and O in 130 (38%). The ABO groups of transplanted grafts and hosts were identical in 97% of cases (335 patients) and compatible in 10 cases. There were no cases of incompatible grafts.During postoperative development, 25 LTs presented arterial thrombosis (7%). Eight grafts presented primary nonfunction and were retransplantated (2.2%), and 43 presented initial poor function that recovered spontaneously (12%).<xref ref-type="bibr" rid="CR3">3</xref> Biopsy-proven acute rejection was diagnosed in 66 grafts (19%) after transplantation, with development to chronic ductopenic rejection in 8 (2%).</p>
      <p><bold>BCs and Rh mismatch</bold> BCs appeared in 70 of the 345 patients (20%). Cross-tabs were built to analyze differences between the grafts that suffered BCs and the rest. Both groups were similar in terms of donor preoperative evaluation and support, recipient descriptive data, and surgical terms. The incidence of BC in nonidentical Rh graft&#x2013;host cases (23/76; 30%) was significantly higher than in cases of identical Rh graft&#x2013;host (47/269; 17%, <italic>P</italic>&#x2009;=&#x2009;0.01). Cases of arterial thrombosis after LTs and ischemia time longer than 430&#xA0;min were also associated with a higher incidence of BC (Table&#xA0;<xref rid="Tab1" ref-type="table">1</xref>). 
<table-wrap id="Tab1"><label>Table&#xA0;1</label><caption><p>Demographics and Major Complications Occurring in Both Groups Studied, Chi-square Test</p></caption><table frame="hsides" rules="groups"><thead><tr><th>&#xA0;</th><th>BCs (<italic>n</italic>&#x2009;=&#x2009;70)</th><th>No BCs (<italic>n</italic>&#x2009;=&#x2009;275)</th><th>Chi-square</th></tr></thead><tbody><tr><td colspan="4">Donor data</td></tr><tr><td>ABO blood group</td><td/><td/><td rowspan="5">0.2</td></tr><tr><td>&#xA0;A</td><td>25/157 (16%)</td><td>132/157 (84%)</td></tr><tr><td>&#xA0;B</td><td>6/29 (21%)</td><td>23/29(79%)</td></tr><tr><td>&#xA0;AB</td><td>6/19 (32%)</td><td>13/19(68%)</td></tr><tr><td>&#xA0;O</td><td>33/140 (24%)</td><td>107/140 (76%)</td></tr><tr><td>Rh blood group</td><td/><td/><td rowspan="3">0.4</td></tr><tr><td>&#xA0;Positive</td><td>59/301 (19%)</td><td>242/301 (81%)</td></tr><tr><td>&#xA0;Negative</td><td>11/44 (25%)</td><td>33/44 (75%)</td></tr><tr><td>Sex</td><td/><td/><td rowspan="3">0.4</td></tr><tr><td>&#xA0;Male</td><td>51/233 (22%)</td><td>182/233 (75%)</td></tr><tr><td>&#xA0;Female</td><td>19/110 (17%)</td><td>91/110 (83%)</td></tr><tr><td>Donor age</td><td/><td/><td rowspan="3">0.4</td></tr><tr><td>&#xA0;&#x2264;70&#xA0;years</td><td>66/320 (20%)</td><td>254/320 (80%)</td></tr><tr><td>&#xA0;&gt;70&#xA0;years</td><td>4/25 (16%)</td><td>21/25 (84%)</td></tr><tr><td colspan="4">Recipient data</td></tr><tr><td>Rh blood group</td><td/><td/><td rowspan="3">0.2</td></tr><tr><td>&#xA0;Positive</td><td>54/284 (19%)</td><td>230/284 (81%)</td></tr><tr><td>&#xA0;Negative</td><td>16/61 (26%)</td><td>45/61 (74%)</td></tr><tr><td>Rh D-R crossing</td><td/><td/><td rowspan="5">0.1</td></tr><tr><td>&#xA0;Positive&#x2013;positive</td><td>45/255 (18%)</td><td>210/255 (82%)</td></tr><tr><td>&#xA0;Positive&#x2013;negative</td><td>14/46 (30%)</td><td>32/46 (70%)</td></tr><tr><td>&#xA0;Negative&#x2013;positive</td><td>9/30 (30%)</td><td>21/30 (70%)</td></tr><tr><td>&#xA0;Negative&#x2013;negative</td><td>2/14 (14%)</td><td>12/14 (86%)</td></tr><tr><td>Rh D-R identity</td><td/><td/><td rowspan="3">0.01</td></tr><tr><td>&#xA0;Identical</td><td>47/269 (17%)</td><td>222/269 (83%)</td></tr><tr><td>&#xA0;Nonidentical</td><td>23/76 (30%)</td><td>53/76 (70%)</td></tr><tr><td>ABO blood group</td><td/><td/><td rowspan="5">0.4</td></tr><tr><td>&#xA0;A</td><td>27/161 (17%)</td><td>134/161 (83%)</td></tr><tr><td>&#xA0;B</td><td>7/34 (20%)</td><td>27/34(80%)</td></tr><tr><td>&#xA0;O</td><td>30/130 (23%)</td><td>100/130(77%)</td></tr><tr><td>&#xA0;AB</td><td>6/20 (30%)</td><td>14/20 (70%)</td></tr><tr><td>ABO D-R identity</td><td/><td/><td rowspan="3">0.4</td></tr><tr><td>&#xA0;Identical</td><td>67/335 (20%)</td><td>268/335 (80%)</td></tr><tr><td>&#xA0;Nonidentical</td><td>3/10 (30%)</td><td>7/10 (70%)</td></tr><tr><td>Sex of recipient</td><td/><td/><td rowspan="3">0.4</td></tr><tr><td>&#xA0;Male</td><td>48/214(22%)</td><td>166/214 (78%)</td></tr><tr><td>&#xA0;Female</td><td>22/130(17%)</td><td>108/130(83%)</td></tr><tr><td>Recipient age</td><td/><td/><td rowspan="3">0.2</td></tr><tr><td>&#xA0;&lt;60&#xA0;years</td><td>41/221 (18%)</td><td>180/221 (82%)</td></tr><tr><td>&#xA0;&#x2265;60&#xA0;years</td><td>29/124 (24%)</td><td>95/124 (76%)</td></tr><tr><td>Diagnosis</td><td/><td/><td rowspan="7">0.3</td></tr><tr><td>&#xA0;Choleostasis</td><td>2/14(15%)</td><td>12/14(85%)</td></tr><tr><td>&#xA0;Cirrhosis</td><td>32/162 (20%)</td><td>130/162(80%)</td></tr><tr><td>&#xA0;Hepatocarcinoma</td><td>27/103(26%)</td><td>76/103(74%)</td></tr><tr><td>&#xA0;Other etiology</td><td>1/18(5%)</td><td>17/18(95%)</td></tr><tr><td>&#xA0;Re-OLT</td><td>7/39(18%)</td><td>32/39 (89%)</td></tr><tr><td>&#xA0;Other tumors</td><td>1/9(11%)</td><td>8/9 (89%)</td></tr><tr><td colspan="4">Surgical data</td></tr><tr><td>Cold ischemic time</td><td/><td/><td rowspan="3">0.01</td></tr><tr><td>&#xA0;&#x2264;430&#xA0;min</td><td>26/178 (15%)</td><td>148/178 (85%)</td></tr><tr><td>&#xA0;&gt;430&#xA0;min</td><td>44/171 (26%)</td><td>127/171 (74%)</td></tr><tr><td>Type of anastomosis</td><td/><td/><td rowspan="2">0.6</td></tr><tr><td>&#xA0;Termino-terminal</td><td>64/315(20%)</td><td>251/315(80%)</td></tr><tr><td colspan="4">Graft evolution data</td></tr><tr><td>Arterial thrombosis</td><td/><td/><td rowspan="3">0.03</td></tr><tr><td>&#xA0;Yes</td><td>9/25 (36%)</td><td>16/25(64%)</td></tr><tr><td>&#xA0;No</td><td>60/319 (19%)</td><td>259/319(81%)</td></tr><tr><td>Initial poor function</td><td/><td/><td rowspan="3">0.6</td></tr><tr><td>&#xA0;Yes</td><td>10/43 (23%)</td><td>33/43 (77%)</td></tr><tr><td>&#xA0;No</td><td>60/302 (20%)</td><td>242/302 (80%)</td></tr><tr><td>Primary nonfunction</td><td/><td/><td rowspan="3">0.1</td></tr><tr><td>&#xA0;Yes</td><td>0</td><td>8/8 (100%)</td></tr><tr><td>&#xA0;No</td><td>70/336 (20%)</td><td>266/336 (80%)</td></tr><tr><td>Acute rejection</td><td/><td/><td rowspan="3">0.4</td></tr><tr><td>&#xA0;Yes</td><td>11/66(17%)</td><td>55/66(83%)</td></tr><tr><td>&#xA0;No</td><td>59/279(21%)</td><td>220/279(79%)</td></tr><tr><td>Chronic rejection</td><td/><td/><td rowspan="3">0.5</td></tr><tr><td>&#xA0;Yes</td><td>1/8(12%)</td><td>7/8(88%)</td></tr><tr><td>&#xA0;No</td><td>69/337 (20%)</td><td>268/337(80%)</td></tr></tbody></table><table-wrap-foot><p><italic>OLT</italic> orthotopic liver transplantation</p></table-wrap-foot></table-wrap></p>
      <sec id="Sec4">
        <title>Multivariate Analysis of Risk Factors for BCs</title>
        <p>In multivariate analysis, arterial thrombosis presented an adjusted relative risk (aRR)&#x2009;=&#x2009;2.6, CI 95%&#x2009;=&#x2009;(1.1&#x2013;6.4) (<italic>P</italic>&#x2009;=&#x2009;0.02), cold ischemia time aRR&#x2009;=&#x2009;1.8 (CI 95% &#x2009;=&#x2009;1&#x2013;3.2) (<italic>P</italic>&#x2009;=&#x2009;0.02), and Rh graft&#x2013;host nonidentity aRR&#x2009;=&#x2009;2 (CI 95%&#x2009;=&#x2009;1.1&#x2013;3) (<italic>P</italic>&#x2009;=&#x2009;0.02) were confirmed as independent risk factors for BC. Other variables included in the initial analysis were nonsignificant (Table&#xA0;<xref rid="Tab2" ref-type="table">2</xref>). Kaplan&#x2013;Meier estimator and log-rank test confirmed these findings (<italic>P</italic>&#x2009;=&#x2009;0.01, Fig.&#xA0;<xref rid="Fig1" ref-type="fig">1</xref>). To discard the possible association between the Rh match and the two other risk factors, we demonstrated that arterial thrombosis had similar incidence in Rh-nonidentical grafts (3/75, 4%) and in Rh-identical grafts (22/269, 8%; <italic>P</italic>&#x2009;=&#x2009;0.1). Moreover, grafts with long ischemia times (&gt;430&#xA0;min) had similar incidence in the Rh-nonidentical (42/76, 55%) group and in Rh-identical patients (129/269, 48%; <italic>P</italic>&#x2009;=&#x2009;0.1). 
<table-wrap id="Tab2"><label>Table&#xA0;2</label><caption><p>Biliary Complications</p></caption><table frame="hsides" rules="groups"><thead><tr><th>&#xA0;</th><th>Univariate logistic regression</th><th>Multivariate logistic regression</th></tr></thead><tbody><tr><td>Donor age &gt;70&#xA0;years</td><td>0.5</td><td>0.7</td></tr><tr><td>Rh D-R identity identical nonidentical</td><td>0.01; 2(1.1&#x2013;3.6)</td><td>0.02; 2 (1.1&#x2013;3.6)</td></tr><tr><td>Cold ischemic time &gt;430&#xA0;min</td><td>0.01; 1.9(1.1&#x2013;3.3)</td><td>0.02; 1.8(1&#x2013;3.2)</td></tr><tr><td>Arterial thrombosis (yes)</td><td>0.04; 2.4(1&#x2013;5.7)</td><td>0.02; 2.6 (1.1&#x2013;6.4)</td></tr><tr><td>Acute rejection (yes)</td><td>0.4</td><td>0.4</td></tr><tr><td>Chronic rejection (yes)</td><td>0.5</td><td>0.5</td></tr></tbody></table><table-wrap-foot><p>Univariate and multivariate logistic regression.</p></table-wrap-foot></table-wrap><fig id="Fig1"><label>Figure&#xA0;1</label><caption><p>Kaplan&#x2013;Meier estimates for the onset of BCs for nonidentical Rh graft&#x2013;host (<italic>P</italic>&#x2009;=&#x2009;0.01).</p></caption><graphic position="anchor" xlink:href="11605_2007_116_Fig1_HTML" id="MO1"/></fig></p>
      </sec>
      <sec id="Sec5">
        <title>Type and Management of BCs</title>
        <p>BCs were diagnosed in 70 patients. Biliary duct anastomosis stricture was the main complication, presented clinically, with (7/10%) or without postoperative leak (21/30%). Solitary leaks (17/24%), ischemic-type BCs (ITBC) with arterial thrombosis (6/9%), ITBC without arterial thrombosis (10/14%), and lithiasis (9/13%) were also related complications. The therapeutic approach was surgical in 23 patients (33%), endoscopic in 20 (28%), retransplantation in 11 (16%), and conservative treatment in 16 (23%).</p>
        <p>Chi-square test was performed to analyze differences between the type of BC and the three risk factors found. As would be expected, arterial thrombosis was identified in all the cases of ITBC with thrombosis, in a higher percentage than the other BCs (<italic>P</italic>&#x2009;&lt;&#x2009;0.001). However, the different types of BCs were not associated with long ischemia time (<italic>P</italic>&#x2009;=&#x2009;0.2) or Rh-identity (<italic>P</italic>&#x2009;=&#x2009;0.4).</p>
        <p>Finally, chi-square test was also performed to analyze differences among the three BC risk factors and medical management. The therapeutic approach regarding Rh-mismatch was similar in both groups (<italic>P</italic>&#x2009;=&#x2009;0.3). Retransplantation was a frequent approach in arterial thrombosis management (4/9, 40%; <italic>P</italic>&#x2009;=&#x2009;0.04). Interestingly, when the BC was presented in grafts with short ischemic time (&lt;430&#xA0;min), management by surgery (10/26, 38%) or an endoscopic approach (10/26, 38%) were sufficient, and it was not necessary to retransplant. However, when the BC arose in a graft with a long ischemic time (&gt;430&#xA0;min) the management was more aggressive, with 29% of patients (13/44) needing surgery and 25% (11/44) needing retransplantation.</p>
      </sec>
    </sec>
    <sec id="Sec6" sec-type="discussion">
      <title>Discussion</title>
      <sec id="Sec7">
        <title>Etiopathogenesis of BC</title>
        <p>Currently, orthotopic liver transplants are performed with good results at several centers without taking the donor&#x2013;recipient Rh relationship into account. In fact, no prior work has shown greater morbidity or mortality after the usage of Rh-incompatible liver grafts. However, it was in studying the causes of BC in our grafts in prior studies that we began to suspect the existence of a possible relationship between BC and Rh incompatibility. First, we observed a greater rate of BC in the presence of preservation lesions in postreperfusion biopsies.<xref ref-type="bibr" rid="CR10">10</xref> Thus, we found that the biliary epithelium is very sensitive to changes during preservation. Second, the description of lesions like ITBC,<xref ref-type="bibr" rid="CR11">11</xref> to which surgical technique does not contribute as a primary cause, led us to suspect possible immunological pathogenesis of the BC. Lastly, it is paradoxical to find that, while surgical technique is improving and satisfactory results are achieved in liver transplants, BCs are still a problem, leading us to suspect that there are unidentified factors that cause them. The arterial thrombosis and long cold ischemia time were independent risk factors for developing BC, as was expected and reported by others.<xref ref-type="bibr" rid="CR11">11</xref>,<xref ref-type="bibr" rid="CR12">12</xref> In our study we have demonstrated that even though BC in grafts with short ischemia can be resolved with surgery or endoscopy, the prognosis of BC was worse in cases of long ischemic grafts requiring retransplantation.</p>
      </sec>
      <sec id="Sec8">
        <title>Relationship Between ABO and Rh in Liver Transplants</title>
        <p>As for the donor&#x2013;recipient ABO relationship, the usage of ABO-incompatible grafts has been discouraged due to the high rate of BC and poor graft survival.<xref ref-type="bibr" rid="CR6">6</xref>,<xref ref-type="bibr" rid="CR13">13</xref>,<xref ref-type="bibr" rid="CR14">14</xref> In the Sanchez-Urdazpal study,<xref ref-type="bibr" rid="CR6">6</xref> 82% of the 18 ABO-incompatible grafts presented BC in comparison with 6% of the control group, while Farges,<xref ref-type="bibr" rid="CR14">14</xref> published slightly better results several years later with BC of 54%. Therefore, these grafts are used in extremely urgent cases when there is no other possible alternative. Immunological phenomena, such as rejection,<xref ref-type="bibr" rid="CR3">3</xref> may also lead to biliary strictures. In the same way, the ABO system was shown to cause more BC and worse graft survival in LT.<xref ref-type="bibr" rid="CR6">6</xref>,<xref ref-type="bibr" rid="CR13">13</xref>&#x2013;<xref ref-type="bibr" rid="CR15">15</xref> However, Rh nonidentity seems to have better tolerance and is not a cause of graft refusal when a donor appears. Surprisingly, our study demonstrated a higher incidence of BC in the Rh-nonidentical group.</p>
        <p>Some authors<xref ref-type="bibr" rid="CR16">16</xref>,<xref ref-type="bibr" rid="CR17">17</xref> reported low rates of alloimmunization in Rh-negative recipients of Rh-incompatible transfusion after LT. It was suspected that immunosuppressant drugs modified the immunosuppressive response.<xref ref-type="bibr" rid="CR16">16</xref> However, debate still exists as to whether the D barrier can be crossed in LT. Previous studies of ABO barrier and BC suggested the hypothesis of an immunological injury to the bile duct epithelium, and the expression of ABH antigens in the donor 150&#xA0;days after transplantation.<xref ref-type="bibr" rid="CR6">6</xref> However, the D antigen is only expressed in erythrocytes.</p>
        <p>The nonidentical Rh group has two mismatch possibilities: positive donor to a negative recipient or negative donor to positive recipient. In the first case (positive to negative) the immunologic mechanism is easy to understand because the humoral anti-D (Rh) response may be responsible for the graft injury.</p>
        <p>The other subgroup (negative to positive) may have a different pathogenic explanation. Bryan et al.<xref ref-type="bibr" rid="CR17">17</xref> hypothesized that two mechanisms could be involved in the same process in kidney transplantation: other Rh antigenic loci (C and E) and histocompatibility antigenic crossings. A negative liver graft in a positive recipient with lymphatic cells and tissues predisposes to cellular response against it. Finally, the biliary tract can probably suffer immunological damage, and thus further BC. Therefore, while the results of the study lead to suspicion of an immunological pathogenesis, the mechanism is still unclear.</p>
        <p>In conclusion, Rh-nonidentical LT involves a higher rate of BCs. Future studies should examine the influence of Rh donor and blood group on graft development. Finally, our results suggest that there is a summation effect of BC risk factors. In our opinion, Rh-nonidentical liver grafts should not undergo a very long ischemia time.</p>
      </sec>
    </sec>
  </body>
  <back>
    <ref-list id="Bib1">
      <title>References</title>
      <ref id="CR1">
        <label>1.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Greif</surname>
              <given-names>F.</given-names>
            </name>
            <name>
              <surname>Bronsther</surname>
              <given-names>O. L.</given-names>
            </name>
            <name>
              <surname>Thiel</surname>
              <given-names>D. H.</given-names>
            </name>
            <name>
              <surname>Casavilla</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Iwatzuki</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Tzakis</surname>
              <given-names>A.</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>The incidence, timing, and management of biliary tract complications after orthotopic liver transplantation</article-title>
          <source>Annals of Surgery</source>
          <year>1994</year>
          <volume>219</volume>
          <fpage>40</fpage>
          <lpage>45</lpage>
          <pub-id pub-id-type="doi">10.1097/00000658-199401000-00007</pub-id>
        </citation>
        <citation citation-type="display-unstructured">Greif, F., Bronsther, O. L., Van Thiel, D. H., Casavilla, A., Iwatzuki, S., Tzakis, A., et al. (1994). The incidence, timing, and management of biliary tract complications after orthotopic liver transplantation. Annals of Surgery, 219, 40&#x2013;45. <pub-id pub-id-type="pmid">8297175</pub-id></citation>
      </ref>
      <ref id="CR2">
        <label>2.</label>
        <citation citation-type="book">
          <person-group person-group-type="author">
            <name>
              <surname>Colonna</surname>
              <given-names>J. O.</given-names>
            </name>
          </person-group>
          <person-group person-group-type="editor">
            <name>
              <surname>Busutil</surname>
              <given-names>R. W.</given-names>
            </name>
            <name>
              <surname>Klintmalmm</surname>
              <given-names>G. B.</given-names>
            </name>
          </person-group>
          <article-title>Technical problems: biliary</article-title>
          <source>Transplantation of the liver</source>
          <year>1996</year>
          <edition>1</edition>
          <publisher-loc>Philadelphia</publisher-loc>
          <publisher-name>Saunders</publisher-name>
          <fpage>617</fpage>
          <lpage>625</lpage>
        </citation>
        <citation citation-type="display-unstructured">Colonna, J. O. (1996). Technical problems: biliary. In R. W. Busutil &amp; G. B. Klintmalmm (Eds.), Transplantation of the liver, 1st edn (pp. 617&#x2013;625). Philadelphia: Saunders. </citation>
      </ref>
      <ref id="CR3">
        <label>3.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Oguma</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Belles</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Starzl</surname>
              <given-names>T. E.</given-names>
            </name>
            <name>
              <surname>Demetris</surname>
              <given-names>A. J.</given-names>
            </name>
          </person-group>
          <article-title>A histometric analysis of chronically rejected human liver allografts: insights into the mechanisms of bile duct loss: direct immunologic and ischemic factors</article-title>
          <source>Hepatology</source>
          <year>1989</year>
          <volume>9</volume>
          <fpage>204</fpage>
          <lpage>209</lpage>
          <pub-id pub-id-type="doi">10.1002/hep.1840090207</pub-id>
        </citation>
        <citation citation-type="display-unstructured">Oguma, S., Belles, S., Starzl, T. E., &amp; Demetris, A. J. (1989). A histometric analysis of chronically rejected human liver allografts: insights into the mechanisms of bile duct loss: direct immunologic and ischemic factors. Hepatology, 9, 204&#x2013;209. <pub-id pub-id-type="pmid">2643544</pub-id></citation>
      </ref>
      <ref id="CR4">
        <label>4.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Li</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Stratta</surname>
              <given-names>R. J.</given-names>
            </name>
            <name>
              <surname>Langnas</surname>
              <given-names>A. N.</given-names>
            </name>
            <name>
              <surname>Wood</surname>
              <given-names>P.</given-names>
            </name>
            <name>
              <surname>Marujo</surname>
              <given-names>W.</given-names>
            </name>
            <name>
              <surname>Shaw</surname>
              <given-names>B. W.</given-names>
            </name>
          </person-group>
          <article-title>Diffuse biliary tract injury after orthotopic liver transplantation</article-title>
          <source>American Journal of Surgery</source>
          <year>1992</year>
          <volume>164</volume>
          <fpage>536</fpage>
          <lpage>540</lpage>
          <pub-id pub-id-type="doi">10.1016/S0002-9610(05)81196-1</pub-id>
        </citation>
        <citation citation-type="display-unstructured">Li, S., Stratta, R. J., Langnas, A. N., Wood, P., Marujo, W., Shaw, B. W. (1992). Diffuse biliary tract injury after orthotopic liver transplantation. American Journal of Surgery, 164, 536&#x2013;540. <pub-id pub-id-type="pmid">1443384</pub-id></citation>
      </ref>
      <ref id="CR5">
        <label>5.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Belzer</surname>
              <given-names>F. O.</given-names>
            </name>
            <name>
              <surname>D&#x2019;Alessandro</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Hoffman</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>Kalayoglu</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Sollinger</surname>
              <given-names>H.</given-names>
            </name>
          </person-group>
          <article-title>Management of common bile duct in extended preservation of the liver</article-title>
          <source>Transplantation</source>
          <year>1992</year>
          <volume>53</volume>
          <fpage>1166</fpage>
          <lpage>1167</lpage>
          <pub-id pub-id-type="doi">10.1097/00007890-199205000-00041</pub-id>
        </citation>
        <citation citation-type="display-unstructured">Belzer, F. O., D&#x2019;Alessandro, A., Hoffman, R., Kalayoglu, M., &amp; Sollinger, H. (1992). Management of common bile duct in extended preservation of the liver. Transplantation, 53, 1166&#x2013;1167. <pub-id pub-id-type="pmid">1585486</pub-id></citation>
      </ref>
      <ref id="CR6">
        <label>6.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sanchez-Urdazpal</surname>
              <given-names>L.</given-names>
            </name>
            <name>
              <surname>Batts</surname>
              <given-names>K. P.</given-names>
            </name>
            <name>
              <surname>Gores</surname>
              <given-names>G. J.</given-names>
            </name>
            <name>
              <surname>Moore</surname>
              <given-names>S. B.</given-names>
            </name>
            <name>
              <surname>Sterioff</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Wiesner</surname>
              <given-names>R. H.</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Increased bile duct complications in liver transplantations across ABO barrier</article-title>
          <source>Annals of Surgery</source>
          <year>1993</year>
          <volume>218</volume>
          <fpage>152</fpage>
          <lpage>158</lpage>
          <pub-id pub-id-type="doi">10.1097/00000658-199308000-00006</pub-id>
        </citation>
        <citation citation-type="display-unstructured">Sanchez-Urdazpal, L., Batts, K. P., Gores, G. J., Moore, S. B., Sterioff S., Wiesner, R. H., et al. (1993). Increased bile duct complications in liver transplantations across ABO barrier. Annals of Surgery, 218, 152&#x2013;158. <pub-id pub-id-type="pmid">8342994</pub-id></citation>
      </ref>
      <ref id="CR7">
        <label>7.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Starzl</surname>
              <given-names>T. E.</given-names>
            </name>
            <name>
              <surname>Hakala</surname>
              <given-names>T. R.</given-names>
            </name>
            <name>
              <surname>Shaw</surname>
              <given-names>B. W.</given-names>
            </name>
            <name>
              <surname>Hardesty</surname>
              <given-names>R. L.</given-names>
            </name>
            <name>
              <surname>Rosenthal</surname>
              <given-names>T. J.</given-names>
            </name>
            <name>
              <surname>Griffith</surname>
              <given-names>B. P.</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>A flexible procedure for multiple cadaveric organ procurement</article-title>
          <source>Surgery, Gynecology &amp; Obstetrics</source>
          <year>1984</year>
          <volume>158</volume>
          <fpage>223</fpage>
          <lpage>230</lpage>
        </citation>
        <citation citation-type="display-unstructured">Starzl, T. E., Hakala, T. R., Shaw, B. W. Jr., Hardesty, R. L., Rosenthal, T. J., Griffith, B. P., et al. (1984). A flexible procedure for multiple cadaveric organ procurement. Surgery, Gynecology &amp; Obstetrics, 158, 223&#x2013;230. </citation>
      </ref>
      <ref id="CR8">
        <label>8.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Fabregat</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Fradera</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>Figueras</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Rafecas</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Torras</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Casanovas</surname>
              <given-names>T.</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Hepatic allograft rejection under quadruple immunosuppressive regimen with cyclosporine A in liver transplantation: incidence of viral and fungal infection</article-title>
          <source>Transplantation Proceedings</source>
          <year>1994</year>
          <volume>26</volume>
          <fpage>2697</fpage>
          <lpage>2699</lpage>
        </citation>
        <citation citation-type="display-unstructured">Fabregat, J., Fradera, R., Figueras, J., Rafecas, A., Torras, J., Casanovas, T. et al. (1994). Hepatic allograft rejection under quadruple immunosuppressive regimen with cyclosporine A in liver transplantation: incidence of viral and fungal infection. Transplantation Proceedings, 26, 2697&#x2013;2699. <pub-id pub-id-type="pmid">7940845</pub-id></citation>
      </ref>
      <ref id="CR9">
        <label>9.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ludwig</surname>
              <given-names>J.</given-names>
            </name>
          </person-group>
          <article-title>Classification and terminology of hepatic allograft rejection: whither bound</article-title>
          <source>Mayo Clinic Proceedings</source>
          <year>1989</year>
          <volume>64</volume>
          <fpage>676</fpage>
          <lpage>679</lpage>
        </citation>
        <citation citation-type="display-unstructured">Ludwig, J. (1989). Classification and terminology of hepatic allograft rejection: whither bound? Mayo Clinic Proceedings, 64, 676&#x2013;679. <pub-id pub-id-type="pmid">2664363</pub-id></citation>
      </ref>
      <ref id="CR10">
        <label>10.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Busquets</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Figueras</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Serrano</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Torras</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Ramos</surname>
              <given-names>E.</given-names>
            </name>
            <name>
              <surname>Fabregat</surname>
              <given-names>J.</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Postreperfusion biopsies are useful in predicting complications after liver transplantation</article-title>
          <source>Liver Transplant</source>
          <year>2001</year>
          <volume>5</volume>
          <fpage>432</fpage>
          <lpage>435</lpage>
          <pub-id pub-id-type="doi">10.1053/jlts.2001.23868</pub-id>
        </citation>
        <citation citation-type="display-unstructured">Busquets, J., Figueras, J., Serrano, T., Torras, J., Ramos. E., Fabregat, J., et al. (2001). Postreperfusion biopsies are useful in predicting complications after liver transplantation. Liver Transplant, 5, 432&#x2013;435. </citation>
      </ref>
      <ref id="CR11">
        <label>11.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sanchez-Urdazapal</surname>
              <given-names>L.</given-names>
            </name>
            <name>
              <surname>Gores</surname>
              <given-names>G. J.</given-names>
            </name>
            <name>
              <surname>Ward</surname>
              <given-names>E. M.</given-names>
            </name>
            <name>
              <surname>Maus</surname>
              <given-names>T. P.</given-names>
            </name>
            <name>
              <surname>Wahlstrom</surname>
              <given-names>H. E.</given-names>
            </name>
            <name>
              <surname>Moore</surname>
              <given-names>S. B.</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Ischemic-type biliary complications after orthotopic liver transplantation</article-title>
          <source>Hepatology</source>
          <year>1992</year>
          <volume>16</volume>
          <fpage>42</fpage>
          <lpage>53</lpage>
          <pub-id pub-id-type="doi">10.1002/hep.1840160110</pub-id>
        </citation>
        <citation citation-type="display-unstructured">Sanchez-Urdazapal, L., Gores, G. J., Ward, E. M., Maus, T. P., Wahlstrom, H. E., Moore, S. B., et al. (1992). Ischemic-type biliary complications after orthotopic liver transplantation. Hepatology, 16, 42&#x2013;53. <pub-id pub-id-type="pmid">1535608</pub-id></citation>
      </ref>
      <ref id="CR12">
        <label>12.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Langas</surname>
              <given-names>A. N.</given-names>
            </name>
            <name>
              <surname>Marujo</surname>
              <given-names>W.</given-names>
            </name>
            <name>
              <surname>Stratta</surname>
              <given-names>R. J.</given-names>
            </name>
            <name>
              <surname>Wood</surname>
              <given-names>R. P.</given-names>
            </name>
            <name>
              <surname>Li</surname>
              <given-names>S. J.</given-names>
            </name>
            <name>
              <surname>Shaw</surname>
              <given-names>B. W.</given-names>
            </name>
          </person-group>
          <article-title>Hepatic allograft rescue following arterial thrombosis: role of urgent revascularization</article-title>
          <source>Transplantation</source>
          <year>1991</year>
          <volume>51</volume>
          <fpage>86</fpage>
          <lpage>90</lpage>
        </citation>
        <citation citation-type="display-unstructured">Langas, A. N., Marujo, W., Stratta, R. J., Wood, R. P., Li, S. J., &amp; Shaw, B. W. (1991). Hepatic allograft rescue following arterial thrombosis: role of urgent revascularization. Transplantation, 51, 86&#x2013;90. <pub-id pub-id-type="pmid">1987710</pub-id></citation>
      </ref>
      <ref id="CR13">
        <label>13.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Guggenheim</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Samuel</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Reynes</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Bismuth</surname>
              <given-names>H.</given-names>
            </name>
          </person-group>
          <article-title>Liver transplantation across ABO blood group barriers</article-title>
          <source>Lancet</source>
          <year>1990</year>
          <volume>336</volume>
          <fpage>519</fpage>
          <lpage>523</lpage>
          <pub-id pub-id-type="doi">10.1016/0140-6736(90)92082-S</pub-id>
        </citation>
        <citation citation-type="display-unstructured">Guggenheim, J., Samuel, D., Reynes, M., &amp; Bismuth, H. (1990). Liver transplantation across ABO blood group barriers. Lancet, 336, 519&#x2013;523. <pub-id pub-id-type="pmid">1975036</pub-id></citation>
      </ref>
      <ref id="CR14">
        <label>14.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Farges</surname>
              <given-names>O.</given-names>
            </name>
            <name>
              <surname>Kalil</surname>
              <given-names>A. N.</given-names>
            </name>
            <name>
              <surname>Samuel</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Saliba</surname>
              <given-names>F.</given-names>
            </name>
            <name>
              <surname>Arulnaden</surname>
              <given-names>J. L.</given-names>
            </name>
            <name>
              <surname>Debat</surname>
              <given-names>P.</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>The use of ABO-incompatible grafts in liver transplantation: a life-saving procedure in highly selected patients</article-title>
          <source>Transplantation</source>
          <year>1995</year>
          <volume>59</volume>
          <issue>8</issue>
          <fpage>1124</fpage>
          <lpage>1133</lpage>
          <pub-id pub-id-type="doi">10.1097/00007890-199504270-00009</pub-id>
        </citation>
        <citation citation-type="display-unstructured">Farges, O., Kalil, A. N., Samuel, D., Saliba, F., Arulnaden, J. L., Debat, P., et al. (1995). The use of ABO-incompatible grafts in liver transplantation: a life-saving procedure in highly selected patients. Transplantation, 59(8), 1124&#x2013;1133. <pub-id pub-id-type="pmid">7732558</pub-id></citation>
      </ref>
      <ref id="CR15">
        <label>15.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lo</surname>
              <given-names>C. M.</given-names>
            </name>
            <name>
              <surname>Shaked</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Drazan</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Yersiz</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Jurim</surname>
              <given-names>O.</given-names>
            </name>
            <name>
              <surname>Busutil</surname>
              <given-names>R. W.</given-names>
            </name>
          </person-group>
          <article-title>Variables affecting transplantation across ABO blood group</article-title>
          <source>Transplantation Proceedings</source>
          <year>1995</year>
          <volume>27</volume>
          <fpage>1159</fpage>
        </citation>
        <citation citation-type="display-unstructured">Lo, C. M., Shaked, A., Drazan, K., Yersiz, H., Jurim, O., &amp; Busutil, R. W. (1995). Variables affecting transplantation across ABO blood group. Transplantation Proceedings, 27, 1159. <pub-id pub-id-type="pmid">7878830</pub-id></citation>
      </ref>
      <ref id="CR16">
        <label>16.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Casanueva</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Valdes</surname>
              <given-names>M. D.</given-names>
            </name>
            <name>
              <surname>Ribera</surname>
              <given-names>M. C.</given-names>
            </name>
          </person-group>
          <article-title>Lack of alloimmunization to D antigen in D-negative immunosuppressed liver transplant recipients</article-title>
          <source>Transfusion</source>
          <year>1994</year>
          <volume>34</volume>
          <fpage>570</fpage>
          <lpage>572</lpage>
          <pub-id pub-id-type="doi">10.1046/j.1537-2995.1994.34794330009.x</pub-id>
        </citation>
        <citation citation-type="display-unstructured">Casanueva, M., Valdes, M. D., &amp; Ribera, M. C. (1994). Lack of alloimmunization to D antigen in D-negative immunosuppressed liver transplant recipients. Transfusion, 34, 570&#x2013;572. <pub-id pub-id-type="pmid">8053037</pub-id></citation>
      </ref>
      <ref id="CR17">
        <label>17.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bryan</surname>
              <given-names>C. F.</given-names>
            </name>
            <name>
              <surname>Mitchell</surname>
              <given-names>S. I.</given-names>
            </name>
            <name>
              <surname>Lin</surname>
              <given-names>J. M.</given-names>
            </name>
            <name>
              <surname>Nelson</surname>
              <given-names>P. W.</given-names>
            </name>
            <name>
              <surname>Shield</surname>
              <given-names>C. F.</given-names>
            </name>
            <name>
              <surname>Luger</surname>
              <given-names>A. M.</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Influence of the Rh (D) blood group system on graft survival in renal transplantation</article-title>
          <source>Transplantation</source>
          <year>1998</year>
          <volume>65</volume>
          <fpage>588</fpage>
          <lpage>592</lpage>
          <pub-id pub-id-type="doi">10.1097/00007890-199802270-00026</pub-id>
        </citation>
        <citation citation-type="display-unstructured">Bryan, C. F., Mitchell, S. I., Lin, J. M., Nelson, P. W., Shield, C. F., III, Luger, A. M., et al. (1998). Influence of the Rh (D) blood group system on graft survival in renal transplantation. Transplantation, 65, 588&#x2013;592. <pub-id pub-id-type="pmid">9500641</pub-id></citation>
      </ref>
    </ref-list>
  </back>
</article>
</pmc-articleset>